Clinical Trials
3 trialsNCT05000294 2026-06-05
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
University of Florida
Phase 1/2 Recruiting
NCT01745367 2020-10-27
BATON-BC
AVEO Pharmaceuticals, Inc.
Phase 2 Terminated
NCT00717340 2012-06-28
A Phase 1b/2a, Open-Label, Multi-Center Study of Tivozanib (AV-951) in Combination With Paclitaxel in Subjects With Advanced or Metastatic Breast Cancer
AVEO Pharmaceuticals, Inc.
Phase 1 Completed